Ardent Health Inc. cash flow to debt ratio of 20.78% indicates that the company cannot generate enough cash to cover its debt over time. This level indicates weak financial health.

Ardent Health Inc.'s free cash flow has increased 102.80% from $127.52M last year to $258.61M, signaling increasing performance

Ardent Health Inc.'s debt to equity ratio is 1.68, which means that the company's assets are unhealthy financed, signaling financial risk.

Ardent Health Inc.'s debt has decreased relative to shareholder equity from 2.02 last year to 1.68 today, signaling strengthened financials

Ardent Health Inc. has a net debt to EBITDA ratio of 3.13x, which exceeds the 3.00x threshold, indicating high leverage and potential financial risk

Ardent Health Inc.'s interest coverage ratio of 9.74 indicates that earnings with good margin can cover interest payments on company debt

Ardent Health Inc.'s profit margin has decreased (65.36%) in the last year from 3.53% to 1.22%, signaling decreasing performance

Ardent Health Inc.'s short-term assets of $2.06B exceed its short-term liabilities of $1.05B

Ardent Health Inc.'s return on assets of 1.48% is lower than the 5.00% threshold, indicating inefficient asset utilization

Ardent Health Inc.'s return on equity of 5.21%, is lower than 15.00%, indicating bad performance

Ardent Health Inc.'s operating cash flow exceeds its net income, indicating high-quality earnings backed by actual cash generation

Ardent Health Inc. has insufficient public price history to evaluate earnings stability.

Ardent Health Inc. has positive free cash flow, indicating the company generates cash after capital expenditures

Ardent Health Inc. has a free cash flow yield of 16.31%, which is above the 2.00% threshold, indicating strong cash generation relative to market value

Ardent Health Inc.'s yearly earnings has decreased 35.43% since last year from $210.34M to $135.81M, signaling decreasing performance

Ardent Health Inc.'s yearly revenue has increased 6.01% since last year from $5.97B to $6.32B, signaling increasing performance

ROIC 9.26% (Source: FMP key-metrics). In the 5–10% partial-credit band. Score: 1 of 2. This band sits within the typical US weighted-average cost of capital range. Methodology choice can change the conclusion: under FMP's invested-capital definition the company is at or near its cost of capital; under narrower operating-capital definitions the same company may score higher. Invested capital here includes equity, non-current liabilities, and short-term debt. Cash is not subtracted. See methodology.

Ardent Health Inc.'s 3-year revenue CAGR of 7.23% is positive, indicating growing revenue over the past 3 years

Ardent Health Inc. has insufficient public price history to evaluate revenue consistency.

Ardent Health Inc. has insufficient public price history to evaluate ROE consistency.

Ardent Health Inc. has insufficient data to evaluate this check.

Ardent Health Inc. has an earnings yield of 4.99%, which is above the 4.00% threshold, indicating the stock offers reasonable value relative to its earnings

Ardent Health Inc. is undervalued relative to its fair value price of 12.68 based on EBITDA multiple model

Ardent Health Inc. has an EV/EBITDA ratio of 6.32x, which is below the 20.00x threshold, indicating reasonable valuation relative to its operating earnings

Ardent Health Inc. has insufficient data to evaluate this check.

Ardent Health Inc. had non-positive diluted EPS five years ago; the PEG ratio is not meaningful and the check fails.

Ardent Health Inc. has a price-to-book ratio of 0.90x, which is below the 5.00x threshold, indicating reasonable valuation relative to its book value

Ardent Health Inc. has a price-to-sales ratio of 0.24x, which is below the 8.00x threshold, indicating reasonable valuation relative to its revenue